LXEO – lexeo therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Lexeo Therapeutics to Host Virtual Key Opinion Leader Event at the 22nd Global Cardiovascular Clinical Trialists (CVCT) Forum
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $19.00 price target on the stock.
Lexeo Therapeutics (NASDAQ:LXEO) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $19.00 price target on the stock.
Lexeo Therapeutics (NASDAQ:LXEO) was upgraded by analysts at Wall Street
Lexeo Therapeutics: Behind The Rebound [Seeking Alpha]
Form EFFECT Lexeo Therapeutics, Inc.
Form 424B3 Lexeo Therapeutics, Inc.
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Townsend Richard Nolan
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: Adler Eric
Form 4 Lexeo Therapeutics, Inc. For: Nov 18 Filed by: See Tai Sandi
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.